AU1926500A - 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases - Google Patents
3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinasesInfo
- Publication number
- AU1926500A AU1926500A AU19265/00A AU1926500A AU1926500A AU 1926500 A AU1926500 A AU 1926500A AU 19265/00 A AU19265/00 A AU 19265/00A AU 1926500 A AU1926500 A AU 1926500A AU 1926500 A AU1926500 A AU 1926500A
- Authority
- AU
- Australia
- Prior art keywords
- proteinases
- inhibitors
- useful
- matrix metallo
- substituted pyrrolidines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 3-substituted pyrrolidines Chemical class 0.000 title 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22445698A | 1998-12-31 | 1998-12-31 | |
| US09224456 | 1998-12-31 | ||
| PCT/US1999/028234 WO2000040553A1 (en) | 1998-12-31 | 1999-11-30 | 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1926500A true AU1926500A (en) | 2000-07-24 |
Family
ID=22840773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU19265/00A Abandoned AU1926500A (en) | 1998-12-31 | 1999-11-30 | 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1150951A1 (en) |
| AR (1) | AR023079A1 (en) |
| AU (1) | AU1926500A (en) |
| CA (1) | CA2356969A1 (en) |
| WO (1) | WO2000040553A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE106087T1 (en) * | 1987-03-17 | 1994-06-15 | Res Corp Technologies Inc | SYNTHETIC INHIBITORS OF MAMMALIAN COLLAGENASE. |
| NZ334490A (en) * | 1996-09-19 | 2000-08-25 | Hoechst Marion Roussel Inc | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives as inhibitors of matrix metalloproteinase |
| JP2001517245A (en) * | 1997-05-29 | 2001-10-02 | メルク エンド カンパニー インコーポレーテッド | Biarylalkanoic acids as cell adhesion inhibitors |
-
1999
- 1999-11-30 WO PCT/US1999/028234 patent/WO2000040553A1/en not_active Ceased
- 1999-11-30 CA CA002356969A patent/CA2356969A1/en not_active Abandoned
- 1999-11-30 AU AU19265/00A patent/AU1926500A/en not_active Abandoned
- 1999-11-30 EP EP99962919A patent/EP1150951A1/en not_active Withdrawn
- 1999-12-30 AR ARP990106860A patent/AR023079A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR023079A1 (en) | 2002-09-04 |
| CA2356969A1 (en) | 2000-07-13 |
| EP1150951A1 (en) | 2001-11-07 |
| WO2000040553A1 (en) | 2000-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1608397A (en) | Heterocyclic compounds useful as pharmaceutical agents | |
| AU8030598A (en) | Indole compounds as cox-2 inhibitors | |
| AU7389300A (en) | Methods of administration of glycopyrrolate compositions | |
| AU4201799A (en) | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors | |
| AU6650198A (en) | Porphyrin compounds as telomerase inhibitors | |
| AU6411698A (en) | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | |
| AU3901100A (en) | Method and composition for waterproofing | |
| AU1463499A (en) | Substituted pyrrole derivatives as cell adhesion inhibitors | |
| AU6462098A (en) | Compounds useful as electrodes and method for preparing same | |
| AU8917098A (en) | Azetidinone derivatives as beta-lactamase inhibitors | |
| AU9317298A (en) | Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors | |
| AU5565099A (en) | Pharmaceutical compositions and methods for use | |
| AU2002213466A1 (en) | Compounds and methods for modulating ccr4 function | |
| AU3827897A (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| AU6056500A (en) | Process and composition for temporarily suppressing pain | |
| AU1605699A (en) | Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii) | |
| AU4315700A (en) | N-substituted dihydropyrrole derivatives | |
| AU3703499A (en) | Substituted indolinones as kinase inhibitors | |
| AU4501199A (en) | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors | |
| AU5338699A (en) | Imidazoles and related compounds as alpha1a agonists | |
| AU3235100A (en) | Prothease inhibitors | |
| AU2424499A (en) | Heterocyclic amidines as callicrein protease inhibitors | |
| AU1817700A (en) | 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 | |
| AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
| AU2938997A (en) | Subsituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |